MediPharm Labs Corp. (LABS) Q4 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Thank you for standing by and welcome to the MetaPharm Labs conference call to discuss its 2025 full year and fourth quarter results. Our speaker on today's call is Greg Hunter, Chief Financial Officer and Interim Chief Executive Officer. As a reminder, all participants are in listen-only mode and the conference is being recorded. After management's presentation, we will take questions from the analyst community on the telephone and then take written questions through the Q&A feature on the webcast. The information during this call should be considered together with the more detailed information disclosure, financial data, and statements available on the company's website and on its Cedar Plus profile at cedarplus.ca. As set out on the webcast slide, I would like to note the remarks During this earnings call may contain forward-looking information and forward-looking statements within the meaning of applicable securities laws. This includes, without limitation, statements about MetaPharm Labs and its current and future plans, expectations, intentions, financial results, operations, levels of activity, performance, goals or achievements, and other future events, trends, probability, business growth, or developments. All statements other than statements of historical fact are forward-looking statements. The statements made are based on the company's current expectations, estimates, and beliefs as of today's date. The company's remarks may also contain reference to non-IFRS financial measures, including adjusted EBITDA. These measures do not have any standardized meaning according to international financial reporting standards, or IFRS, and therefore may not be comparable or similar measures presented by other companies. Please review the company's most recent disclosur...